Gland Pharma’s arm inks share purchase agreement with FPCI Sino French Midcap Fund

07 Jan 2023 Evaluate

Gland Pharma's wholly owned subsidiary -- Gland Pharma International PTE, Singapore has entered into a share purchase agreement with FPCI Sino French Midcap Fund to acquire 100% stake in Europe-based Cenexi Group pursuant to the terms of the put option agreement inked in November last year.

Earlier, the company through its wholly owned subsidiary -- Gland Pharma International PTE, Singapore had entered into a Put Option agreement to acquire 100% of Cenexi Group for an equity value not exceeding Euro 120 million (Enterprise Value of Euro 230 million).

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1850.15 11.00 (0.60%)
03-Jun-2024 15:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1453.35
Dr. Reddys Lab 5781.00
Cipla 1452.85
Zydus Lifesciences 1032.00
Lupin 1585.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.